AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study NCT05706142 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Motor Imagery Education
Description: Within the scope of motor imagery training, a presentation will be made to the students of pediatric rehabilitation lecture in the intervention group about what motor imagery is. PETTLEP model will be used for imagery training. In this model, imagery training will be prepared in accordance with our purpose, taking into account the physical, environmental, time, task, learning, emotion and personal subheadings. In the training sessions, relaxation exercises will be given for 5 minutes first. After the relaxation exercises, special colic massage imagery training will be given to newborns for 10 minutes. The massage will also be shown as practically at class.
Study NCT06061289 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: EXPERIMENTAL
Intervention: SP Detox Program
Description: The production use and disposal of toxic chemicals and synthetic materials have increased the risk of exposure to health-threatening toxins. Causal relationships between toxic chemicals and diseases have been well established. However, many patients endure chronic symptoms that are associated with exposure to toxins before advanced stages of specific diseases are realized. Thus, there is a great demand for noninvasive laboratory tests that can provide timely assessment of chemical exposure and the capability of hepatic detoxification
Study NCT05615831 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Resistance Training with Blood flow restriction
Description: Participants will perform six weeks of blood flow restriction (60% occlusion) combined with resistance training at 30% of 1RM. The intervention comprises five exercises: incline chest press, seated row, leg press, knee extension, and knee flexion. The protocol is as follows: 30 repetitions followed by three sets of 15 repetitions for a total of four sets and 75 repetitions per exercise. There will be a one-minute recovery between sets where the cuffs remain inflated and a four-minute recovery between exercises where the cuffs will be deflated.
Study NCT06346366 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Bihormonal artificial pancreas (BIHAP) / closed loop
Description: The investigational device is a dual-hormonal fully closed loop system (BIHAP; industrial name AP® 5, Inreda Diabetic B.V.) which aims at optimally controlling plasma glucose levels. This BIHAP contains of two pumps for subcutaneous infusion of either insulin (Humalog, 3 ml pre-fill cartridge, Eli Lilly) or glucagon (GlucaGen, Novo Nordisk; 3.15 ml cartridge Accu-Chek Spirit, Roche) via an infusion set (Accu-Chek Insight Flex or AccuChek Flex Link, Roche), two subcutaneously placed glucose-sensors (Guardian, Medtronic) and an algorithm driving pump infusion rates based on the sensor input. Daily self-measurements of blood glucose (SMBGs; Accu-Chek Instant, Roche) are needed for calibration of the glucose sensors.~The BIHAP-system has to be worn continuously, except while showering.
Study NCT06346366 — intervention group
Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: Bihormonal artificial pancreas (BIHAP) / closed loop
Description: The investigational device is a dual-hormonal fully closed loop system (BIHAP; industrial name AP® 5, Inreda Diabetic B.V.) which aims at optimally controlling plasma glucose levels. This BIHAP contains of two pumps for subcutaneous infusion of either insulin (Humalog, 3 ml pre-fill cartridge, Eli Lilly) or glucagon (GlucaGen, Novo Nordisk; 3.15 ml cartridge Accu-Chek Spirit, Roche) via an infusion set (Accu-Chek Insight Flex or AccuChek Flex Link, Roche), two subcutaneously placed glucose-sensors (Guardian, Medtronic) and an algorithm driving pump infusion rates based on the sensor input. Daily self-measurements of blood glucose (SMBGs; Accu-Chek Instant, Roche) are needed for calibration of the glucose sensors.~The BIHAP-system has to be worn continuously, except while showering.
Study NCT05615337 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: MBSR
Description: The MBSR is an eight-week group-based psychoeducational program. It is performed in weekly group sessions with the duration of 2.5 hours and a half-day retreat of 4 hours.~The program involves focused attention, consisting of body scan, yoga, and meditation. This program trains participants to be attentive to their thoughts, emotions, and sensations. There are also discussions on relevant topics related to the physiology of stress and strategies of coping. Materials for home practice are provided.
Study NCT05615337 — intervention group
Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: HPP
Description: The HPP has the same structure of MBSR, including different components such as music, nutrition, cognitive enhancement, risk factors for dementia, and physical activity. During the half-day retreat participants are involved in watercolor painting activities. Materials for home practice are also provided.
Study NCT05244460 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Droperidol Injectable Product
Description: Treatment
Study NCT04118140 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Somatic Acupressure
Description: 7-week self-acupressure plus usual care (an education booklet)
Study NCT04118140 — intervention group
Intervention type: OTHER
Group type: SHAM_COMPARATOR
Intervention: Sham acupressure
Description: Same dose as the true acupressure group but on the sham acupoints plus usual care (an education booklet)
Study NCT04118140 — intervention group
Intervention type: OTHER
Group type: SHAM_COMPARATOR
Intervention: Usual care
Description: Usual care only (an education booklet)
Study NCT05244460 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Diphenhydramine
Description: Treatment
Study NCT04615260 — intervention group
Intervention type: DEVICE
Group type: OTHER
Intervention: NanoBone
Description: Nanobone® Synthetic Bone Graft is a nanocrystalline hydroxyapatite imbedded in a silica gel matrix. The nanocrystalline structure accurately replicates autologous hydroxyapatite and the silica gel matrix that rapidly transforms into an osteogenic matrix post-implantation. NanoBone promotes remodeling by acting as a strong osteoinductive material. NanoBone® is available as a putty.
Study NCT04118140 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Usual care
Description: Usual care only (an education booklet)
Study NCT04118140 — intervention group
Intervention type: OTHER
Group type: OTHER
Intervention: Usual care
Description: Usual care only (an education booklet)
Study NCT06289088 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: First Intervention
Description: Firstly, For individuals with low back pain, all measurements will be evaluated without wearing any orthosis. The waist circumference of individuals with low back pain will be measured and the orthosis was adapted to the appropriate orthosis size by the prosthetist orthotist. After waiting with the orthosis for half an hour, the measurements will be repeated. Then, the person will be asked to wear the orthosis without any intervention.
Study NCT06289088 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Second Intervention
Description: Firstly, The waist circumference of individuals with low back pain will be measured and the orthosis will be adapted to the appropriate orthosis size by the prosthetist orthotist. After waiting with the orthosis for half an hour, the person will be asked to wear the orthosis without any intervention and the outcome measurements will be repeated. After waiting with the orthosis for half an hour, all measurements will be evaluated without wearing any orthosis.
Study NCT06289088 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Third Intervention
Description: Firstly, the person will be asked to wear the orthosis without any intervention and the outcome measurements will be done. The waist circumference of individuals with low back pain will be measured and the orthosis will be adapted to the appropriate orthosis size by the prosthetist orthotist. After waiting with the orthosis for half an hour, all measurements will be evaluated without wearing any orthosis. Lastly, The waist circumference of individuals with low back pain will be measured and the orthosis will be adapted to the appropriate orthosis size by the prosthetist orthotis. After waiting with the orthosis for half an hour, all measurements will be evaluated.
Study NCT04947878 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Prompt list
Description: The patients in the intervention group will review a prompt list before their visit.
Study NCT04525989 — intervention group
Intervention type: RADIATION
Group type: ACTIVE_COMPARATOR
Intervention: Radiation therapy
Description: 5 x 5 Gy external radiation therapy
Study NCT04525989 — intervention group
Intervention type: RADIATION
Group type: EXPERIMENTAL
Intervention: Radiation therapy
Description: 5 x 5 Gy external radiation therapy
Study NCT05703620 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Renal Denervation
Description: All eligible participants receive ultrasound based renal denervation to both kidneys on all eligible vessels
Study NCT05497622 — intervention group
Intervention type: DIAGNOSTIC_TEST
Group type: EXPERIMENTAL
Intervention: Quantitative Ultrasound
Description: Ultrasound assessment of Trapezius muscle
Study NCT05497622 — intervention group
Intervention type: DIAGNOSTIC_TEST
Group type: EXPERIMENTAL
Intervention: Osteopathic TART Assessment
Description: Evaluation of the 4 diagnostic criteria:~1. Tissue Texture abnormality~2. Asymmetry~3. Restriction of Motion~4. Tenderness
Study NCT05497622 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Osteopathic Manipulation Treatment
Description: Use of manual techniques such as soft tissue stretching, resisted isometric stretches, fascial relaxation and counter strain.
Study NCT04676308 — intervention group
Intervention type: OTHER
Intervention: Artificial Intelligence
Description: Artificial intelligence
Study NCT05128162 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Psilocybin
Description: Two oral doses of psilocybin in a capsule formulation taken approximately 2 weeks apart.
Study NCT05128162 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Psychotherapy
Description: 1. Pre-dose preparatory sessions; 2. Dosing day monitoring; and, 3. Post-dose integration sessions.
Study NCT05615987 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Onabotulinumtoxina for Injection
Description: 200iu/2ml in both groups
Study NCT05615987 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Onabotulinumtoxina for Injection
Description: 200iu/2ml in both groups
Study NCT04677426 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Hyperpolarized Xe129
Description: Whether magnetic resonance imaging (MRI) using inhaled hyper-polarized 129 Xenon gas can help visualize impaired lung function to assess patients with cHP and IPF.
Study NCT06461585 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Sprint interval training
Description: Group A the Interventional group will receive SIT . Group A will perform SIT 3 times a week for 30-second sprints on a cycle ergometer with 4 minutes of rest between each sprint, complete session will be for 30 -40 minutes. Group B will receive the aerobic exercise. Group B will perform the aerobic exercise for 30-40 minutes of moderate-intensity continuous exercise on a treadmill and stationary cycle
Study NCT06002867 — intervention group
Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: SAPB (Serratus Anterior Plan) Block
Description: The patient will be in the supine position. The area where the procedure will be performed will be cleaned with povidone iodine. Using a 22-gauge, 80 mm insulated Quincke needle with a high frequency (10-18 MHz) ultrasound linear probe covered with a sterile sheath, the latissimus dorsi muscle and the serratus muscle will be visualized at the level of the 4th and 5th ribs. After determining the fascia between the two muscles, the block needle will be advanced from caudal to cranial and 40 ml of 0.25% bupivacaine (local anesthetic) will be injected on the serratus muscle between the two muscles.
Study NCT06306690 — intervention group
Intervention type: DIAGNOSTIC_TEST
Intervention: OCT, OCT angiography, flicker ERG and Ultra Wide Field retinography and autofluorescence.
Description: the best visual acuity will be evaluated using decimal tables and then converted to logMar.~Ocular fundus examination will be evaluated following pharmacological mydriasis with Tropicamide 1%.~OCT will be essential to quantify the central macular thickness and the thickness of the RPE.~OCT angiography is a non-invasive method to assess the presence or absence of neovascular membrane and macular flow density.~Color and ultra wide field autofluorescence images of the retina will be performed with Zeiss Clarus retinography to search for signs that identify different types of RP and predict their activity and evolution.~Electroretinogram flicker (ERG) is a common measure of cone pathway function that is used to study the normal visual system and that of patients with inherited and acquired retinal dysfunction Measurements will be performed using an electrophysiological recording system (CSO). Intermittent stimuli are presented using a Ganzfeld dome (CSO).
Study NCT06122883 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Evaluation the effectiveness of distraction in the reception area in the management of anxious pediatric patients during dental local anesthesia
Description: Buccal and palatal infiltration will be administrated with basic behavior guidance techniques while the dentist wearing conventional attire in the treatment room after meeting the child in the reception area while wearing the friendly attire.
Study NCT06122883 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Evaluation the effectiveness of distraction in the treatment area in the management of anxious pediatric patients during dental local anesthesia
Description: Buccal and palatal infiltration will be administrated with basic behavior guidance techniques while the dentist wearing friendly attire in the treatment room after meeting the child in the reception area while wearing the conventional attire.
Study NCT06122883 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Evaluation the effectiveness of distraction in both reception and treatment areas in the management of anxious pediatric patients during dental local anesthesia
Description: Buccal and palatal infiltration will be administrated with basic behavior guidance techniques while the dentist wearing friendly attire in the reception area and treatment room.
Study NCT06122883 — intervention group
Intervention type: BEHAVIORAL
Group type: OTHER
Intervention: Evaluation of the effectiveness of basic behavior guidance techniques without using any type of distraction aids in the management of anxious pediatric patients during dental local anesthesia
Description: Buccal and palatal infiltration will be administrated with basic behavior guidance techniques while the dentist wearing conventional attire in the reception area and treatment room.
Study NCT04909502 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: EHP-101 25 mg OD
Description: 25 mg OD during the first 28 Days of the trial
Study NCT04909502 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: EHP-101 25 mg BID
Description: 25 mg BID during the first 28 Days of the trial
Study NCT04909502 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: EHP-101 50 mg OD
Description: After 28 Days of treatment with 25 mg OD, patients will escalate to 50 mg OD up to the end of the trial
Study NCT04909502 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: EHP-101 50 mg BID
Description: After 28 Days of treatment with 25 mg BID, patients will escalate to 50 mg BID up to the end of the trial
Study NCT04330794 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: NMFACT
Description: caries index
Study NCT04330794 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: DMF index
Description: caries index chart to collect data about decayed missed filled teeth
Study NCT04793997 — intervention group
Intervention type: BIOLOGICAL
Group type: ACTIVE_COMPARATOR
Intervention: Microbiome spray
Description: Throat spray containing 3 beneficial lactobacilli strains
Study NCT04793997 — intervention group
Intervention type: BIOLOGICAL
Group type: PLACEBO_COMPARATOR
Intervention: Placebo spray
Description: Throat spray
Study NCT05182580 — intervention group
Intervention type: DIAGNOSTIC_TEST
Group type: EXPERIMENTAL
Intervention: Results utilized from autonomous AI diagnostic system for diabetic retinopathy and/or diabetic macular edema
Description: If patients receive a negative result they do not see the retina specialist
Study NCT05265884 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Kinesiotaping
Description: The tape is waterproof, porous, and adhesive. The width is 5 cm and thickness of 0.5 mm will be used in this study. This tape is with elastic core wrapped within cotton and capable of stretching up to 140-150%, applies heat-sensitive acrylic adhesive to avoid risk of latex allergy .The tape without medicinal properties is water resistant and can remain on the skin for 3 to 5 days. It will be applied two times per week for one month
Study NCT05265884 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: traditional therapy intervention
Description: traditional treatment (ROM exercises, stretching exercises, and Deep friction message) 3 times per week for one month.
Study NCT05265884 — intervention group
Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: traditional therapy intervention
Description: traditional treatment (ROM exercises, stretching exercises, and Deep friction message) 3 times per week for one month.
Study NCT05210868 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: CM355
Description: 1. Dose Escalation Phase CM355 will be taken by patients and will be treated follow the 3+3 dose escalation scheme~2. Expansion Phase CM355 will be taken by patients and will assess the efficacy of CM355 in patients with specific histopathological Non-Hodgkin's Lymphoma, and the safety of drug
Study NCT04367103 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Norepinephrine
Description: prophylaxis for hypotension
Study NCT04367103 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Phenylephrine
Description: standerd prophylaxis for hypotension
Study NCT05063747 — intervention group
Intervention type: OTHER
Intervention: No intervention.
Description: Observational study. No intervention.
Study NCT05011214 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Sevoflurane
Description: All patients received 0.01 mg/kg atropine and 1ug/kg dexmedetomidine iv as premedication.5% sevoflurane(FIO2=100%, 3L·min-1) was used to induce anaesthesia by mask inhalation and 3-4 % sevoflurane (adjusted according to the depth of the anaesthesia,FIO2=100%, 2L·min-1) was maintained
Study NCT05011214 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Esketamine
Description: All patients received 0.1 mg/kg atropine and 1ug/kg dexmedetomidine iv as premedication.0.5mg·kg-1 esketamine was administered by vein in one minute, and 0.25mg·kg-1 esketamine was given at the beginning of the surgery.
Study NCT05873179 — intervention group
Intervention type: OTHER
Intervention: role-playing for learning the clinical interview
Description: role-playing for learning the clinical interview
Study NCT06200974 — intervention group
Intervention type: RADIATION
Intervention: High dose rate prostate brachytherapy
Description: Temporary implantation of radioactive material into the prostate in the form of a stepping source of Iridium 192 that travels through 16-18 needles or catheters strategically placed through the prostate.
Study NCT06496438 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: ACTIVE_COMPARATOR
Intervention: Psychobiotics
Description: Dietary Supplement: A four probiotic regime, containing Lactobacillus rhamnosus, Bifidobacterium animalis subsp. lactis, Bifidobacterium breve, and Bifidobacterium longum at a concentration of 1, 000,000,000 CFU.
Study NCT06496438 — intervention group
Intervention type: OTHER
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: The placebo regime, containing powdered glucose polymer, will be identical in packaging, appearance, consistency, and solubility in drinking water, thus making it impossible to recognize which are placebo and which the therapeutic formulation. Both will be identically standardized by the same pharmaceutical company \[Uni-Pharma, Greece\].
Study NCT05736705 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Endoscopic Submucosal Dissection
Description: Participants randomized in this arm will have the removal of their esophageal lesion utilizing the monopolar electrocautery knife.
Study NCT05736705 — intervention group
Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Endoscopic Submucosal Dissection
Description: Participants randomized in this arm will have the removal of their esophageal lesion utilizing the monopolar electrocautery knife.
Study NCT05736705 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Bipolar electrocautery knife
Description: Participants randomized in this arm will have the removal of their esophageal lesion utilizing the bipolar electrocautery knife.
Study NCT03990207 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: PowerSpiral Enteroscopy System
Description: Motorized spiral enteroscopy system
Study NCT04298866 — intervention group
Intervention type: OTHER
Group type: OTHER
Intervention: Experimental Arm
Description: * 3T MRI, maximum 1H30 long duration, including diffusion tensor imaging, susceptibility weighted imaging, multiparametric acquisitions, without contrast perfusion acquisitions.~* 7T MRI, maximum 1H30 long duration, including contrast enhanced acquisitions~* Neuropsychological battery including chronometric measures obtained through a computer interface
Study NCT04774497 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Oxygen inhalation treatment group
Description: Oxygen inhalation group: oxygen inhalation was started on the first day of chemotherapy, and the oxygen inhalation volume was 2 L / min, 8 hours / day for 3 consecutive days.
Study NCT04774497 — intervention group
Intervention type: OTHER
Group type: PLACEBO_COMPARATOR
Intervention: Control group
Description: The control group was not given oxygen inhalation.
Study NCT06093230 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Deuremidevir Hydrobromide Tablets
Description: JT001 single dose, 0.3g